Altertox PBPK Modeling and Quantitative In Vitro-In Vivo Extrapolations
Physiologically based pharmacokinetic (PBPK) modelling plays a crucial role in next generation (non-animal) risk evaluations to inform the design of in vitro studies and to convert the data obtained with in vitro models into human dose−response or potency information. The goal of the course is to acquaint participants with setting up PBPK models based on non-animal input parameters and to subsequently use these models to extrapolate in vitro bioassay data to human dose-response or potency information. The course is co-organised and hosted at Wageningen University.
For additional information, click this link.